Can allogeneic stem cells improve outcomes after stroke?
作者信息
Cramer Steven C
机构信息
Department of Neurology, Department of Anatomy and Neurobiology, Sue and Bill Gross Stem Cell Research Center, University of California, Irvine 92697-1385, CA, USA; Department of Physical Medicine and Rehabilitation, Sue and Bill Gross Stem Cell Research Center, University of California, Irvine 92697-1385, CA, USA.
出版信息
Lancet Neurol. 2017 May;16(5):335-336. doi: 10.1016/S1474-4422(17)30075-3. Epub 2017 Mar 17.
Abstract
摘要
相似文献
1
Can allogeneic stem cells improve outcomes after stroke?同种异体干细胞能改善中风后的预后吗？
Lancet Neurol. 2017 May;16(5):335-336. doi: 10.1016/S1474-4422(17)30075-3. Epub 2017 Mar 17.
2
Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.移植改良骨髓间充质干细胞治疗中风的临床结果：一项1/2a期研究。
Stroke. 2016 Jul;47(7):1817-24. doi: 10.1161/STROKEAHA.116.012995. Epub 2016 Jun 2.
3
Mesenchymal stem cell therapy in treatment of erectile dysfunction: autologous or allogeneic cell sources?间充质干细胞疗法治疗勃起功能障碍：自体还是异体细胞来源？
Int J Urol. 2014 Dec;21(12):1280-5. doi: 10.1111/iju.12585. Epub 2014 Jul 30.
4
Mesenchymal Stem Cell Therapy for Ischemic Stroke.间充质干细胞治疗缺血性中风
Acta Med Okayama. 2017 Aug;71(4):263-268. doi: 10.18926/AMO/55302.
5
Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.马关节腔内注射自体、异体和异种间充质干细胞后的免疫反应研究。
Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):99-106. doi: 10.1016/j.vetimm.2013.09.003. Epub 2013 Sep 18.
6
Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.多能间充质基质细胞在异基因造血干细胞移植中的联合移植：一项系统评价和荟萃分析。
Cytotherapy. 2016 Feb;18(2):172-85. doi: 10.1016/j.jcyt.2015.11.010.
7
8
Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges.人脐带间充质干细胞植入治疗缺血性脑卒中：前景与挑战
Front Med. 2015 Mar;9(1):20-9. doi: 10.1007/s11684-014-0371-x. Epub 2014 Dec 9.
9
Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.细胞外囊泡可改善中风后的神经再生并预防缺血后免疫抑制。
Stem Cells Transl Med. 2015 Oct;4(10):1131-43. doi: 10.5966/sctm.2015-0078. Epub 2015 Sep 3.
10
Challenges and research progress of the use of mesenchymal stem cells in the treatment of ischemic stroke.间充质干细胞用于治疗缺血性中风的挑战与研究进展
Brain Dev. 2018 Aug;40(7):612-626. doi: 10.1016/j.braindev.2018.03.015. Epub 2018 Apr 13.
本文引用的文献
1
Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.多能成体祖细胞治疗急性缺血性脑卒中的安全性和有效性研究（MASTERS）：一项随机、双盲、安慰剂对照、2 期临床试验。
Lancet Neurol. 2017 May;16(5):360-368. doi: 10.1016/S1474-4422(17)30046-7. Epub 2017 Mar 17.
2
Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.中风恢复与康复研究：问题、机遇与美国国立卫生研究院中风网络
Stroke. 2017 Mar;48(3):813-819. doi: 10.1161/STROKEAHA.116.015501. Epub 2017 Feb 7.
3
Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.《成人中风康复与恢复指南：美国心脏协会/美国中风协会给医疗保健专业人员的指南》
Stroke. 2016 Jun;47(6):e98-e169. doi: 10.1161/STR.0000000000000098. Epub 2016 May 4.
4
Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease.间充质干细胞在移植物抗宿主病治疗与预防中的临床应用
Adv Hematol. 2011;2011:427863. doi: 10.1155/2011/427863. Epub 2011 Dec 10.
5
Harnessing neuroplasticity for clinical applications.利用神经可塑性进行临床应用。
Brain. 2011 Jun;134(Pt 6):1591-609. doi: 10.1093/brain/awr039. Epub 2011 Apr 10.
6
Selective neuronal loss in rescued penumbra relates to initial hypoperfusion.挽救半暗带中的选择性神经元丢失与初始灌注不足有关。
Brain. 2008 Oct;131(Pt 10):2666-78. doi: 10.1093/brain/awn175. Epub 2008 Aug 4.
7
The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents.在促进中风恢复药物临床试验中采用特定模态结局指标的理由。
Stroke. 2007 Apr;38(4):1393-5. doi: 10.1161/01.STR.0000260087.67462.80. Epub 2007 Mar 1.
8
Considerations in the design of clinical trials of neuroprotective therapy in acute stroke.急性卒中神经保护治疗临床试验设计中的考量因素。
Stroke. 1996 Sep;27(9):1507-15. doi: 10.1161/01.str.27.9.1507.
9
Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy.为什么所有药物在动物身上都有效，但对中风患者却都无效？2. 神经保护疗法。
J Intern Med. 1995 Jan;237(1):89-94. doi: 10.1111/j.1365-2796.1995.tb01145.x.
Zotero 插件